ArticleCellular oncology (Dordrecht, Netherlands)2024

Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression.

Kunwei Peng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.